Related Experiment Video
Updated: Jul 13, 2025

10:28
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
15.2K
Electroencephalogram-Driven Machine-Learning Scenario for Assessing Impulse Control Disorder Comorbidity in
Summary
This study introduces an electroencephalogram (EEG)-based machine learning tool to detect impulse control disorders (ICDs) in Parkinson's disease (PD) patients on dopamine agonist (DA) therapy. The system shows promise for early risk assessment in daily environments.
Area of Science:
- Neuroscience
- Computational Psychiatry
- Biomedical Engineering
Background:
- Parkinson's disease (PD) patients on dopamine agonist (DA) therapy may develop impulse control disorders (ICDs).
- Cognitive and motor comorbidities significantly increase disability and mortality in PD patients.
- Automatic assessment of ICD comorbidity is crucial for managing PD patients.
Purpose of the Study:
- To develop and validate an electroencephalogram (EEG)-driven machine learning approach for automatic ICD assessment in PD.
- To differentiate PD patients with ICD from those without, and estimate ICD severity.
- To explore the potential of a low-cost, wearable system for real-world application.
Main Methods:
- Utilized a Go/NoGo task to record EEG activity during cognitive and motor inhibition tasks.
- Employed a support vector machine (SVM) for ICD detection and support vector regression (SVR) for severity estimation.
- Trained and tested models on a dataset comprising PD patients with and without ICD, and healthy controls.
Main Results:
- The SVM model achieved 66.3% accuracy in differentiating PD patients with ICD from those without.
- The SVR model showed significantly higher severity scores in the ICD group compared to the PD group.
- The EEG-based approach demonstrated potential for distinguishing ICD presence and severity, outperforming random guessing.
Conclusions:
- An EEG-driven machine learning pipeline can effectively assess ICD comorbidity in PD patients.
- This technology may facilitate the development of wearable computer-aided diagnosis systems for early risk assessment.
- The findings support proactive monitoring for DA-triggered cognitive comorbidities in PD patients.

